Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1166 of 5804
-
New flu pill for teens shows promise in Late-Stage trial
Symptom relief Recruiting nowThis randomized, double-blind, placebo-controlled study is designed to evaluate the efficacy and safety of Onradivir Tablets in participants aged 12 to 17 years with influenza A virus infection. The trial plans to enroll approximately 150 adolescent participants (12-17 years) wi…
Phase: PHASE3 • Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New arthritis drug shows promise in Long-Term safety trial
Disease control ENROLLING_BY_INVITATIONThis is a study to demonstrate the long-term safety, tolerability and clinical efficacy of sonelokimab in the treatment of patients with psoriatic arthritis who completed a parental study (M1095-PSA-301 or M1095-PSA-302)
Phase: PHASE3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New score could help doctors spot fungal pneumonia faster
Diagnosis Recruiting nowThe FUNGAL-P study is a single-center observational study designed to derive and validate a clinical prediction score for the early identification of fungal pneumonia in adult patients presenting with pneumonia. The study includes a retrospective derivation cohort and a prospect…
Sponsor: Azienda Ospedaliero-Universitaria Careggi • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New Antibody-Drug conjugate KIVU-107 enters first human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis is a 2-part, first-in-human, open-label study to determine the safety and tolerability of KIVU-107, a PTK7-directed antibody-drug conjugate, in participants with locally advanced or metastatic solid tumors.
Phase: PHASE1 • Sponsor: Kivu Bioscience Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug cocktail aims to fight Hard-to-Treat cancers
Disease control Recruiting nowThis study adopts a multi-center, open-label, non-randomized trial design. It plans to enroll patients with Advanced solid tumor. Dose-escalation and PK-expansion studies will be carried out to evaluate the safety, tolerability, and preliminary efficacy of sirolimus (albumin-boun…
Phase: PHASE1, PHASE2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a simple antibiotic combo stop stubborn joint infections?
Disease control Recruiting nowThis is a prospective, multicenter, randomized controlled study. Patients were evaluated through inclusion and exclusion criteria. Patients who meet the conditions will sign an informed consent form. After DAIR surgery, they will be treated with intravenous antibiotics for 1-2 we…
Phase: NA • Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a daily pill replace frequent blood tests for heart valve patients?
Disease control ENROLLING_BY_INVITATIONWarfarin is the standard anticoagulant used for patients with mechanical heart valves; however, its use is complicated by a narrow therapeutic window, frequent drug and dietary interactions, and the need for regular international normalized ratio (INR) monitoring. In resource-lim…
Phase: PHASE3 • Sponsor: Rawalpindi Institute of Cardiology • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
AI-Powered selfies could spot gum disease without a dentist visit
Diagnosis Not yet recruitingThis is a multi-center, cross-sectional diagnostic study aimed at evaluating the accuracy of various non-invasive methods-including self-reported questionnaires, intra-oral photographs, smartphone images, intraoral scans (IOS), and orthopantomographs (OPGs)-in detecting periodont…
Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Diagnosis
Last updated Jun 26, 2026 16:01 UTC
-
Radioactive drug takes aim at Hard-to-Treat sarcoma
Disease control Recruiting nowThe goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S. Additionally Ratio Therapeutics will learn if \[Ac225\]RTX-2358 drug is effective in treating advanced sarcoma. The main questions the stud…
Phase: PHASE1 • Sponsor: Ratio Therapeutics, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
AI steps in to ease Chemo's toll: new trial for cancer patients
Symptom relief Recruiting nowThis two-stage adaptive randomized controlled trial evaluates the feasibility and preliminary efficacy of large language model (LLM)-assisted intervention for managing chemotherapy side effects in patients with solid tumors. Adults with histologically confirmed breast or colorect…
Phase: NA • Sponsor: Incheon St.Mary's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New drug duo aims to keep relapsed germ cell cancer in check
Disease control Recruiting nowThis is an open label, single arm phase I/II trial of maintenance zanzalintinib in combination with oral etoposide in patients with relapsed GCT treated with HDCT and PBSCT with a safety lead-in cohort in patients with relapsed, refractory metastatic GCT.
Phase: PHASE1, PHASE2 • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New triple attack on advanced cancers enters human testing
Disease control Recruiting nowThe goal of this clinical trial is to assess the safety and tolerability of AT1019 when used in combination with SBRT and PD-1 inhibitor, and determine the maximum tolerated dose (MTD) of AT1019 in the combination therapy of SBRT and PD-1 inhibitor in patients with advanced solid…
Phase: PHASE1 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Heart patients get flu shot at discharge to prevent future attacks
Prevention Recruiting nowPatients hospitalized for acute cardiac conditions-including acute myocardial infarction, acute heart failure, pulmonary embolism, arrhythmias, and hypertensive emergencies-represent a heterogeneous population at very high risk of recurrent cardiovascular events. Influenza infect…
Phase: PHASE4 • Sponsor: Wroclaw Medical University • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
New hope for advanced tumors? first human trial of 7MW4911 begins
Disease control Recruiting nowThis is the first-in-human study of 7MW4911 in Chinese patients, to investigate its prelimary safety and efficacy in patients with Advanced Solid Tumors.
Phase: PHASE1, PHASE2 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Pacemaker showdown: which type helps heart failure patients most?
Disease control Recruiting nowThe goal of this clinical trial is to find out which type of specialist pacemaker-known as cardiac resynchronisation therapy (CRT)-works best for people with heart failure and a delay in how the lower chambers of the heart beat together (called electrical dyssynchrony). The main…
Phase: NA • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Weekly pill could cut migraine days in half
Disease control Recruiting nowThe goal of this randomized, placebo-controlled, double-blind clinical trial is to evaluate the efficacy, safety, and tolerability of cabergoline for the prevention of episodic migraine in adults with 4-14 monthly migraine days (MMD). The main questions it aims to answer are: 1.…
Phase: PHASE2 • Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Breast cancer gene test could unlock personalized treatments for thousands
Knowledge-focused Recruiting nowThis study aims to provide information about the genomics of your breast cancer which your oncologist can use to enhance the treatment of your disease possibly enabling more targeted and personalised therapy.This study will carry out TruSight Oncology Comprehensive (TSOComprehens…
Phase: NA • Sponsor: Cancer Trials Ireland • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Experimental vaccine targets HPV-16 tumors in early trial
Disease control Recruiting nowThis is a phase I, open-label, dose escalation study to assess the safety, tolerability, efficacy and immunogenicity of TI-0093 injection in patients with recurrent or metastatic HPV-16 positive solid tumors. The primary objectives of the study are to assess safety and tolerabil…
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Video game controlled by brain waves could revolutionize cognitive testing for kids with disabilities
Diagnosis Recruiting nowThis project aims to validate an EEG-based brain-computer interface (BCI) game as a cognitive assessment tool for children with motor impairments. Traditional cognitive assessments often rely on motor responses, which may underestimate the abilities of children with limited mobil…
Sponsor: University of Alberta • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
One scan, two checks: could a quick abdominal CT during lung screening catch kidney cancer early?
Diagnosis Recruiting nowEarly detection through screening can improve cancer survival by identifying it when it's most treatable. The NHS now offers Lung Cancer Screening (LCS) assessments to people aged 55-74 who have ever smoked. Those at higher risk of lung cancer are offered a lung scan. This group…
Phase: NA • Sponsor: University of Cambridge • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC